Cargando…
17‐β‐estradiol reduces surface PD‐L1 expression in estrogen receptor‐positive breast cancer but not type 1 endometrial cancer cells
Autores principales: | Li, Hongzhuo, Gu, Wenyi, Jeffery, Penny, Chen, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345460/ https://www.ncbi.nlm.nih.gov/pubmed/37448208 http://dx.doi.org/10.1002/ctm2.1330 |
Ejemplares similares
-
17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells
por: Belkaid, Anissa, et al.
Publicado: (2015) -
Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer
por: Blanchard, Zannel, et al.
Publicado: (2019) -
The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane
por: Acconcia, Filippo, et al.
Publicado: (2011) -
The Contribution of 17beta-Hydroxysteroid Dehydrogenase Type 1 to the Estradiol-Estrone Ratio in Estrogen-Sensitive Breast Cancer Cells
por: Zhang, Chen-Yan, et al.
Publicado: (2012) -
Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
por: Rangel, Nelson, et al.
Publicado: (2017)